Promising Phase III Melanoma Results Build on Research Conducted at Georgetown Lombardi
August 19th, 2026
A promising new approach to preventing high-risk melanoma from recurring after surgery has yielded positive results in a large clinical trial, building on earlier research that included investigators and patients at Georgetown University’s Lombardi Comprehensive Cancer Center.…

